Confluent reticulated papillomatosis https://en.wikipedia.org/wiki/Confluent_and_reticulated_papillomatosis
Ang Confluent reticulated papillomatosis ay isang hindi pangkaraniwan ngunit kakatangi‑tanging ichthyosiform dermatosis na nailalarawan sa pamamagitan ng patuloy na madilim, nangangaliskis, at mga patak na kadalasang nakalocalize sa gitnang bahagi ng katawan. Ang sakit ay maaaring gamutin gamit ang Minocycline.

Paggamot
#Minocycline
Karagdagang informasiyon ― Filipino
References Confluent and Reticulated Papillomatosis 29083642 
NIH
Confluent and reticulated papillomatosis (CRP), na tinatawag ding Gougerot‑Carteaud syndrome, ay nagreresulta mula sa abnormal na paglaki ng selula ng balat. Lumalabas ito bilang mga walang sakit na dark spot na maaaring sumanib sa mas malalaking patch, kadalasang lumalabas sa itaas na dibdib at leeg ng mga teenager at young adult. Ang unang pagpipilian sa paggamot ay minocycline.
Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.
 Confluent and reticulated papillomatosis: diagnostic and treatment challenges 27601929 
NIH
Karaniwang lumilitaw ang CRP bilang mga madidilim na spot at patch na walang ibang sintomas sa balat, kadalasan sa paligid ng leeg, kilikili, itaas na dibdib, at itaas na likod. Minsan, maaaring kumalat ito hanggang sa noo at pababa sa pubic area. Ang mga antibiotic tulad ng minocycline ay naging paboritong pagpipilian sa paggamot.
CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.